External Radiation Therapy

Automatic Contouring in CT for Treatment Planning in Radiation Therapy

Radiation Therapy requires careful treatment planning to achieve tumor control while minimizing the radiation delivered to organs at risk (OARs) — anatomical structures located close to the target volume. Treatment plans are defined following specific protocols by radiation oncologists and medical physicists to ensure that the prescribed dose is delivered to each volume. Dose data resulting from treatment planning enables the calculation of dose-volume histograms (DVH) on each volume of interest previously delineated by the radiation oncologist.

We have developed a deep learning-based segmentation approach for head and neck anatomy that uses a separated three-dimensional (3D) CNN architecture for delineating each independent structure. We trained and validated our segmentation approach on a dataset of 35 CT scans that include 6 segmented labels obtained from routine clinical head and neck RT treatment planning at Hospital General Universitario Gregorio Marañón (HGUGM) in Madrid. We also evaluated our approach on images from the MICCAI2015 head and neck challenge. We obtained DICE coefficients from 0.8 to 0.9 for brainstem, spinal cord, eyes and parotid glands.

Moreover, we have recently published a deep learning-based methodology to segment fifteen OARs exploiting a partially-labeled longitudinal database. Data was acquired from CLCC Eugène Marquis in Rennes, France, and included CT scans and segmented labels for 48 patients treated with head and neck radiotherapy. Our methodology comprised two steps. First, we used the available ground truth labels for each OAR to train a OAR-specific 3D UNet. These models were used to generate pseudo-labels for the missing contours. Finally, we trained a multi-class nnU-Net for finer OAR segmentation. Results were robust, with an average DICE score coefficient of 80.59%. We demonstrated the robustness of our method and its easy integration into the clinical RT workflow.

  • Cubero, L.; Castelli, J.; Simon, A.; de Crevoisier, R.; Acosta, O.; Pascau, J. Deep Learning-Based Segmentation of Head and Neck Organs-at-Risk with Clinical Partially Labeled Data. Entropy 2022, 24, 1661. [doi]
  • Lucía Cubero, Antoine Simon, Joël Castelli, Renaud de Crevoisier, Javier Serrano, Óscar Acosta, Javier Pascau. Deep Learning-based Workflow to Speed Up Organ-at-Risk Segmentation in Head and Neck Radiotherapy. NVIDIA GTC Conference 2022. Watch online at: https://www.nvidia.com/en-us/on-demand/session/gtcspring22-p42480/
  • M. Concepción-Brito, R. Moreta-Martinez, J. Serrano, D. García-Mato, M. García-Sevilla, J. Pascau. Segmentation of Organs at Risk in Head and Neck Radiation Therapy with 3D Convolutional Networks. In: CARS 2019 – Computer Assisted Radiology and Surgery Proceedings of the 33rd International Congress and Exhibition, Rennes, France, June 18–21, 2019. Int J CARS 14, 27–28 (2019). [doi] [UC3M Research Portal]

Personalized Planning in RadioTherapy (PerPlanRT)

Radiotherapy for prostate cancer (PC) involves irradiation not only of the target volume but also of portions of healthy neighboring Organs at Risk (OaR) such as bladder, rectum or penile bulb. RT-induced morbidity of sexual, urinary, or rectal nature can arise, impacting Quality of life (QoL). Predicting toxicities to devise personalized treatments with reduced RT-induced morbidity and maximized local control is a crucial question in RT. 

PerPlanRT is a consortium including partners from different European countries (Spain, France, Italy) that will work together to devise innovative decision-making tools aimed at proposing integrated and feasible strategies for personalized RT in PC with reduced RT-induced toxicities (rectal, urinary, sexual) aimed at improving QoL.

Our group will focus on automatic methods that will contour not only Organs at Risk, but also those regions that have been identified as predictive for RT-induced toxicity. We are also working on accelerating image registration with Deep Learning to facilitate voxel-wise analysis.

Video explaining PerPlanRT project for Asociación Española Contra el Cáncer

The project started in April 2021 and will finish in 2024 and is supported by Instituto de Salud Carlos III (AC20-00102 and AC20-00123) and Asociación Española Contra el Cáncer under the frame of ERA PerMed.

More information

Research supported by projects PI18/01625 and AC20/00102 (Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Asociación Española Contra el Cáncer and European Regional Development Fund “Una manera de hacer Europa”), IND2018/TIC-9753 (Comunidad de Madrid) and project PrePlanRT (ERA Permed).